Literature DB >> 21860231

Septic acute kidney injury: the culprit is inflammatory apoptosis rather than ischemic necrosis.

R Jacobs1, P M Honore, O Joannes-Boyau, W Boer, J De Regt, E De Waele, V Collin, H D Spapen.   

Abstract

For a long time, acute kidney injury (AKI) was considered to be a primarily hemodynamic condition characterized by a reduction of renal blood flow, induced by either cardiogenic or distributive (septic) shock. Consequently, all efforts to treat AKI were essentially concentrated on increasing renal flow by enhancing cardiac flow output and perfusion pressure. At the beginning of this decade, Bellomo and co-workers produced new and intriguing data in an animal model of septic AKI that undermined existing concepts. They observed that medullar and cortical renal blood flow were both maintained and even increased in septic shock, underscoring that septic AKI was a totally different physiological phenomenon than nonseptic AKI. Also, apoptosis was found to play a more important role in sepsis and septic shock than pure necrosis. Despite these findings, the role of apoptosis as a main mechanism of organ dysfunction remains topic of debate.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21860231     DOI: 10.1159/000330244

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  22 in total

1.  Histopathological changes in septic acute kidney injury in critically ill children: a cohort of post-mortem renal biopsies.

Authors:  Ramachandran Rameshkumar; Sriram Krishnamurthy; Rajesh Nachiappa Ganesh; Subramanian Mahadevan; Parameswaran Narayanan; Ponnarmeni Satheesh; Puneet Jain
Journal:  Clin Exp Nephrol       Date:  2016-10-13       Impact factor: 2.801

Review 2.  Cellular apoptosis in the cardiorenal axis.

Authors:  Grazia Maria Virzì; Anna Clementi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 3.  Acute kidney injury clinical trial design: old problems, new strategies.

Authors:  Zoltán H Endre; John W Pickering
Journal:  Pediatr Nephrol       Date:  2012-05-26       Impact factor: 3.714

4.  Transcription factor nuclear factor erythroid 2 p45-related factor 2 (NRF2) ameliorates sepsis-associated acute kidney injury by maintaining mitochondrial homeostasis and improving the mitochondrial function.

Authors:  Zhijiang Chen; Huili Wang; Bin Hu; Xinxin Chen; Meiyu Zheng; Lili Liang; Juanjuan Lyu; Qiyi Zeng
Journal:  Eur J Histochem       Date:  2022-06-21       Impact factor: 1.966

Review 5.  Fluid management for the prevention and attenuation of acute kidney injury.

Authors:  John R Prowle; Christopher J Kirwan; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

Review 6.  The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5.

Authors:  Anna Clementi; Grazia Maria Virzì; Alessandra Brocca; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2017-06-24       Impact factor: 2.041

7.  Mechanisms of cardiac and renal dysfunction in patients dying of sepsis.

Authors:  Osamu Takasu; Joseph P Gaut; Eizo Watanabe; Kathleen To; R Eliot Fagley; Brian Sato; Steve Jarman; Igor R Efimov; Deborah L Janks; Anil Srivastava; Sam B Bhayani; Anne Drewry; Paul E Swanson; Richard S Hotchkiss
Journal:  Am J Respir Crit Care Med       Date:  2013-01-24       Impact factor: 21.405

8.  Extravascular lung water monitoring of renal replacement therapy in lung water scavenging for septic acute kidney injury.

Authors:  Han Liu; Ying Liu; Jia-Kui Sun; Qiao-Lian Xu; Ying Yan; Yong-Ming Chen; Liang Hong; Huan Xu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  Acute kidney injury: an intensivist's perspective.

Authors:  John R Prowle
Journal:  Pediatr Nephrol       Date:  2013-01-30       Impact factor: 3.714

10.  Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments.

Authors:  Patrick M Honore; Rita Jacobs; Olivier Joannes-Boyau; Jouke De Regt; Willem Boer; Elisabeth De Waele; Vincent Collin; Herbert D Spapen
Journal:  Ann Intensive Care       Date:  2011-08-09       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.